Menu

• Ask a Health Expert about BLOOD PHOSPHORUS DECREASED
• Post Your Side Effect related to BLOOD PHOSPHORUS DECREASED
• BLOOD PHOSPHORUS DECREASED and FDA Warnings
• BLOOD PHOSPHORUS DECREASED in Patients Wiki
• Report BLOOD PHOSPHORUS DECREASED in Drug Side Effect Survey

BLOOD PHOSPHORUS DECREASED side effect

What is BLOOD PHOSPHORUS DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Escitalopram Side Effects Report #5671401-9
Consumer or non-health professional from FRANCE reported ESCITALOPRAM problem on Feb 26, 2008. Female patient, 89 years of age, was diagnosed with major depression, hypertension, lumbar spinal stenosis, back pain, hypothyroidism and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, condition aggravated, diarrhoea, faeces discoloured, hypomagnesaemia, major depression, malnutrition, overdose, . ESCITALOPRAM dosage: 5 MG QD PO. During the same period patient was treated with ENALAPRIL MALEATE, LYRICA, DURAGESIC, FERROUS SULPHATE, LEVOTHYROXINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Reclast Side Effects Report #5674586-3
RECLAST problem was reported by a Pharmacist from UNITED STATES on Mar 19, 2008. Female patient, weighting 123.9 lb, was diagnosed with osteoporosis and was treated with RECLAST. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, calcium deficiency, . RECLAST dosage: 5MG/100ML ONCE IV BOLUS 1 DOSE. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5677299-7
Health Professional from UNITED STATES reported SPRYCEL problem on Mar 20, 2008. Male patient, weighting 174.4 lb, was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, cough, diarrhoea, influenza like illness, vomiting, . SPRYCEL dosage: 2900 MG. During the same period patient was treated with NEUTRA. Patient recovered.

Carvedilol Side Effects Report #5618884-8
CARVEDILOL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2008. Male patient, 63 years of age, weighting 294.0 lb, was diagnosed with cardiac failure congestive and was treated with CARVEDILOL. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood urea increased, dizziness, extrasystoles, fatigue, lymphocyte percentage decreased, neutrophil percentage increased, refusal of treatment by patient, . CARVEDILOL dosage: 37.5 MG BID PO. During the same period patient was treated with ENALAPRIL MALEATE, ISOSORBIDE DINITRATE, FUROSEMIDE, ALLOPURINOL, ASPIRIN, FOLIC ACID, FISH OIL. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5644322-5
Physician from FRANCE reported IMATINIB MESYLATE problem on Feb 20, 2008. Female patient, 66 years of age, weighting 103.6 lb, was diagnosed with gastrointestinal stromal tumour and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, diarrhoea, gastroenteritis, staphylococcal infection, vomiting, . IMATINIB MESYLATE dosage: 400 MG, QD. During the same period patient was treated with VOGALENE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5506009-9
BORTEZOMIB problem was reported by a Pharmacist from UNITED STATES on Nov 01, 2007. Female patient, weighting 158.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with BORTEZOMIB. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, chills, hypotension, incontinence, loss of consciousness, pain, rhabdomyolysis, . BORTEZOMIB dosage: 2.3MG ONCE IV. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Zyprexa Side Effects Report #5509724-6
Physician from FRANCE reported ZYPREXA problem on Nov 06, 2007. Female patient, 49 years of age, weighting 227.1 lb, was diagnosed with psychotic disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood pressure increased, condition aggravated, dyspnoea, ketoacidosis, renal failure, sinus tachycardia, urinary tract infection staphylococcal, weight increased, . ZYPREXA dosage: 10 MG, DAILY (1/D). During the same period patient was treated with LUDIOMIL, DEPAKOTE, NOCTAMIDE. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5528065-4
EXJADE problem was reported by a Physician from FRANCE on Nov 23, 2007. Female patient, child 12 years of age, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood potassium decreased, renal tubular disorder, . EXJADE dosage: 500 MG/DAY. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5528533-5
Physician from FRANCE reported EXJADE problem on Nov 23, 2007. Female patient, child 12 years of age, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood potassium decreased, renal tubular disorder, . EXJADE dosage: 500 MG/DAY. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5440555-1
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Female patient was diagnosed with breast cancer metastatic, colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, mucosal inflammation, red blood cell count decreased, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with ABRAXANE, NEUPOGEN. Patient was hospitalized and became disabled. Patient recovered.

Zolinza Side Effects Report #5447097-8
Health Professional from UNITED STATES reported ZOLINZA problem on Apr 30, 2007. Male patient, 32 years of age, was diagnosed with brain neoplasm malignant and was treated with ZOLINZA. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, . ZOLINZA dosage: 400 MG/DAILY/PO. Patient recovered.

Lithobid Side Effects Report #5379538-9
LITHOBID problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Female patient, 16 years of age, was treated with LITHOBID. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood thyroid stimulating hormone increased, diarrhoea, mania, raynaud's phenomenon, thyroid disorder, . LITHOBID dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Lithobid Side Effects Report #5379538-9
Consumer or non-health professional from UNITED STATES reported LITHOBID problem on June 21, 2007. Female patient, 16 years of age, was treated with LITHOBID. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood thyroid stimulating hormone increased, diarrhoea, mania, raynaud's phenomenon, thyroid disorder, . LITHOBID dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5707282-4
IMATINIB MESYLATE problem was reported by a Physician from FRANCE on Apr 07, 2008. Female patient, 66 years of age, weighting 103.6 lb, was diagnosed with gastrointestinal stromal tumour and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, diarrhoea, gastroenteritis, staphylococcal infection, vomiting, . IMATINIB MESYLATE dosage: 400 MG, QD. During the same period patient was treated with VOGALENE. Patient was hospitalized. Patient recovered.


Furosemide Side Effects Report #5708314-X
Pharmacist from CANADA reported FUROSEMIDE problem on Apr 02, 2008. Male patient, 48 years of age, was diagnosed with ascites, back pain, hiv infection and was treated with FUROSEMIDE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood potassium increased, renal failure, renal tubular necrosis, . FUROSEMIDE dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, NAPROXEN, TENOFOVIR DISOPROXIL FUMARATE, DIDANOSINE, LOPINAVIR W, HYDROMORPHONE, QUININE. Patient died.

Cytarabine Side Effects Report #5375905-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2007. Male patient, weighting 143.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood potassium decreased, hypotension, lobar pneumonia, mucosal inflammation, nausea, oral intake reduced, respiratory distress, sepsis, . CYTARABINE dosage: unknown. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient died on 06/23/2007.

Epzicom Side Effects Report #5292122-0
Consumer or non-health professional from UNITED STATES reported EPZICOM problem on Apr 04, 2007. Male patient, 51 years of age, was diagnosed with hiv infection, acquired immunodeficiency syndrome and was treated with EPZICOM. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood pressure increased, dyspnoea, exercise tolerance decreased, gait disturbance, heart rate increased, hyperventilation, hypoxia, . EPZICOM dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, REYATAZ, NORVIR, CLONAZEPAM, TERAZOSIN, DOXEPIN. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5294003-5
REBIF problem was reported by a Health Professional from UNITED STATES on Mar 29, 2007. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood potassium decreased, hypertension, nephrolithiasis, urinary tract infection, . REBIF dosage: unknown. During the same period patient was treated with LISINOPRIL, COZAAR, NORVASC, MORPHINE, ASPIRIN. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5274752-5
Consumer or non-health professional from UNITED STATES reported REBIF problem on Mar 13, 2007. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: blood phosphorus decreased, blood potassium decreased, hypertension, nephrolithiasis, urinary tract infection, . REBIF dosage: unknown. During the same period patient was treated with LISINOPRIL, COZAAR, NORVASC, MORPHINE, ASPIRIN. Patient was hospitalized. Patient recovered.


Exjade Side Effects Report #5683915-6
EXJADE problem was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Female patient, 38 years of age, weighting 174.2 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, blood urea increased, blood urine present, dehydration, hyperglycaemia, protein total increased, proteinuria, pyrexia, . EXJADE dosage: 2000MG, QD. During the same period patient was treated with LANTUS, HUMALOG, SYNTHROID, ZOLOFT, VICODIN, ATIVAN, PHENERGAN. Patient recovered.

Revlimid Side Effects Report #5622935-4
Health Professional from GERMANY reported REVLIMID problem on Jan 28, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, blood phosphorus decreased, blood potassium decreased, dehydration, diarrhoea, epilepsy, parkinsonism, restlessness, viral infection, . REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE, TAMSULOSIN, DIOVAN, NEXIUM, CIPRO, MOVICOL, ARANESP, FENTANYL. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5629913-X
EXJADE problem was reported by a Consumer or non-health professional from FRANCE on Feb 08, 2008. Female patient, 18 years of age, weighting 121.3 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acidosis, blood phosphorus decreased, blood sodium decreased, condition aggravated, constipation, dizziness, glycosuria, hypokalaemia, paraesthesia, . EXJADE dosage: 1250 MG, QD. Patient was hospitalized. Patient recovered.

Novolin Side Effects Report #5591241-9
Consumer or non-health professional from UNITED STATES reported NOVOLIN N problem on Jan 07, 2008. Female patient was diagnosed with type 1 diabetes mellitus, blood pressure increased, oedema peripheral, multiple sclerosis and was treated with NOVOLIN N. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood phosphorus decreased, influenza, . NOVOLIN N dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN N, NOVOLIN R, NOVOLIN R, NOVOLIN R, ALTACE, FUROSEMIDE, VITAMIN B. Patient was hospitalized. Patient recovered.

Reclast Side Effects Report #5571465-7
RECLAST problem was reported by a Physician from FRANCE on Dec 17, 2007. Male patient, 70 years of age, was diagnosed with osteitis deformans and was treated with RECLAST. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood phosphorus decreased, osteomalacia, urine phosphate increased, . RECLAST dosage: 5 MG, ONCE/SINGLE. During the same period patient was treated with CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.

Didanosine Side Effects Report #5484069-1
Health Professional from UNITED KINGDOM reported DIDANOSINE problem on Oct 09, 2007. Male patient, child 2 years of age, weighting 26.46 lb, was diagnosed with hiv test positive and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased, . DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR. Patient recovered.

Reclast Side Effects Report #5500991-1
RECLAST problem was reported by a Physician from FRANCE on Oct 18, 2007. Male patient, 70 years of age, was diagnosed with osteitis deformans and was treated with RECLAST. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood phosphorus decreased, osteomalacia, . RECLAST dosage: 5 MG, ONCE/SINGLE. During the same period patient was treated with CALCIUM, VITAMIN D. Patient recovered.

Exjade Side Effects Report #5502579-5
Consumer or non-health professional from FRANCE reported EXJADE problem on Oct 23, 2007. Female patient, 18 years of age, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acidosis, blood phosphorus decreased, constipation, dizziness, glycosuria, hypokalaemia, paraesthesia, proteinuria, renal tubular disorder, . EXJADE dosage: 1250 MG, QD. Patient was hospitalized. Patient recovered.

Didanosine Side Effects Report #5453729-0
DIDANOSINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 12, 2007. Female patient, child 5 years of age, weighting 37.48 lb, was diagnosed with hiv test positive and was treated with DIDANOSINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased, . DIDANOSINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Tenofovir Side Effects Report #5429917-6
Consumer or non-health professional from UNITED STATES reported TENOFOVIR DISOPROXIL FUMARATE problem on Aug 20, 2007. Male patient, weighting 6.17 lb, was treated with TENOFOVIR DISOPROXIL FUMARATE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood phosphorus decreased, . TENOFOVIR DISOPROXIL FUMARATE dosage: unknown. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Viread Side Effects Report #5439089-X
VIREAD problem was reported by a Physician from UNITED KINGDOM on Aug 20, 2007. Male patient, child 2 years of age, weighting 26.32 lb, was diagnosed with hiv test positive and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased, . VIREAD dosage: unknown. During the same period patient was treated with DIDANOSINE. Patient recovered.

Viread Side Effects Report #5439090-6
Physician from UNITED KINGDOM reported VIREAD problem on Aug 20, 2007. Female patient, child 5 years of age, weighting 37.48 lb, was diagnosed with hiv test positive and was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood phosphorus decreased, cd4 lymphocytes decreased, . VIREAD dosage: unknown. During the same period patient was treated with DIDANOSINE. Patient recovered.

Depakene Side Effects Report #5380830-2
DEPAKENE problem was reported by a Health Professional from FRANCE on June 28, 2007. Female patient, child 10 years of age, was diagnosed with anoxia, encephalopathy, convulsion and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone decreased, blood phosphorus decreased, hyponatraemia, lung disorder, thrombocytopenia, . DEPAKENE dosage: unknown. During the same period patient was treated with CLONAZEPAM, CLOBAZAM, STIRIPENTOL. Patient was hospitalized. Patient recovered.

Depakene Side Effects Report #5380830-2
Health Professional from FRANCE reported DEPAKENE problem on June 28, 2007. Female patient, child 10 years of age, was diagnosed with anoxia, encephalopathy, convulsion and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone decreased, blood phosphorus decreased, hyponatraemia, lung disorder, thrombocytopenia, . DEPAKENE dosage: unknown. During the same period patient was treated with CLONAZEPAM, CLOBAZAM, STIRIPENTOL. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5758148-5
TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on June 02, 2008. Female patient, weighting 231.5 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood phosphorus decreased, . TAXOL dosage: 172 MG. During the same period patient was treated with CALCIUM, GINSENG, NEULASTA, VITAMEN D, ZOMETA. Patient recovered.

Taxol Side Effects Report #5758926-2
Consumer or non-health professional from UNITED STATES reported TAXOL problem on June 03, 2008. Female patient, weighting 231.5 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood phosphorus decreased, . TAXOL dosage: 172 MG. During the same period patient was treated with CALCIUM, DECADRON, GINSENG, NEULASTA, VITAMEN D, ZOMETA. Patient recovered.

Tacrolimus Side Effects Report #5792333-1
TACROLIMUS problem was reported by a Physician from JAPAN on June 12, 2008. Female patient, child 12 years of age, weighting 58.86 lb, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood phosphorus decreased, cytomegalovirus infection, disease recurrence, escherichia sepsis, focal segmental glomerulosclerosis, haemodialysis, hyperlipidaemia, . TACROLIMUS dosage: 4.00 MG, BID, ORAL, 4 MG, UID/QD, ORAL, 2 MG, D, ORAL, 1.5 MG, BID, ORAL, 2 MG, BID, ORAL,. During the same period patient was treated with PROGRAF. Patient recovered.

Adriamycin Side Effects Report #5350556-X
Physician from UNITED STATES reported ADRIAMYCIN PFS problem on May 22, 2007. Female patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ADRIAMYCIN PFS. After drug was administered, patient experienced the following problems/side effects: amnesia, blood phosphorus decreased, blood sodium decreased, confusional state, dehydration, diarrhoea, disease progression, grand mal convulsion, haemoglobin decreased, . ADRIAMYCIN PFS dosage: 50MG/M2;. Patient was hospitalized. Patient died.

Cetuximab Side Effects Report #5325350-6
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Male patient, 60 years of age, weighting 145.5 lb, was diagnosed with pancreatic carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased, blood phosphorus decreased, . CETUXIMAB dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMZAR. Patient recovered.

Fluorouracil Side Effects Report #5333893-4
Physician from UNITED STATES reported FLUOROURACIL problem on May 07, 2007. Male patient, 79 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood phosphorus decreased, blood potassium decreased, blood urea increased, decreased appetite, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, . FLUOROURACIL dosage: 50.2857 MG (704 MG, 1 IN 2 WK), INTRAVENOUS. During the same period patient was treated with CETUXIMAB, BEVACIZUMAB, LEUCOVORIN CALCIUM, SIMVASTATIN, CALTRATE, MAXIPIME, TOPROL, PROTONIX. Patient was hospitalized. Patient recovered.

Tenofovir Side Effects Report #5338540-3
TENOFOVIR DISOPROXIL FUMARATE problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Male patient, weighting 6.17 lb, was treated with TENOFOVIR DISOPROXIL FUMARATE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood phosphorus decreased, neonatal respiratory distress syndrome, . TENOFOVIR DISOPROXIL FUMARATE dosage: unknown. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Nexavar Side Effects Report #5294446-X
Consumer or non-health professional from UNITED STATES reported NEXAVAR problem on Apr 03, 2007. Male patient, 73 years of age, weighting 160.9 lb, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood phosphorus decreased, insomnia, loss of consciousness, pruritus, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COUMADIN, AVODART, DARVOCET, PROMETHAZINE, FLOMAX, AMBIEN. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5302455-7
FORTEO problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2007. Female patient, 61 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, blood phosphorus decreased, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

Nexavar Side Effects Report #5262283-8
Health Professional from UNITED STATES reported NEXAVAR problem on Mar 07, 2007. Female patient, 80 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: anxiety, blood phosphorus decreased, blood potassium decreased, blood pressure increased, blood sodium decreased, decreased appetite, flushing, nausea, pyrexia, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5651694-4
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 22, 2008. Male patient, 74 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, blood calcium decreased, blood phosphorus decreased, blood urea increased, chronic lymphocytic leukaemia, condition aggravated, platelet count decreased, . REVLIMID dosage: 10 MG, X21 DAYS EVERY 28 DAYS, ORAL; 25 MG, X21 DAYS EVERY 28 DAYS, ORAL. During the same period patient was treated with ALLOPURINOL, DECADRON. Patient was hospitalized. Patient recovered.

Ribashere Side Effects Report #5658012-6
Physician from UNITED STATES reported RIBASHERE problem on Feb 25, 2008. Female patient, weighting 106.0 lb, was diagnosed with hepatitis c and was treated with RIBASHERE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, blood glucose increased, blood phosphorus decreased, brain oedema, carotid artery stenosis, cerebral artery occlusion, cerebral artery thrombosis, cerebrovascular accident, culture urine positive, . RIBASHERE dosage: 800 MG ORAL. During the same period patient was treated with FUROSEMIDE, TOPIRAMATE, PERCOCET, CULTURELLE. Patient was hospitalized. Patient recovered.

Ribashere Side Effects Report #5688093-5
RIBASHERE problem was reported by a Physician from UNITED STATES on Mar 11, 2008. Female patient, weighting 106.0 lb, was diagnosed with hepatitis c and was treated with RIBASHERE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, blood glucose increased, blood phosphorus decreased, brain herniation, carotid artery stenosis, cerebral artery embolism, cerebral artery thrombosis, cerebral infarction, cerebrovascular accident, . RIBASHERE dosage: (800 MG ORAL). During the same period patient was treated with FUROSEMIDE, TOPIRAMATE, PERCOCET, CULTURELLE. Patient was hospitalized. Patient recovered.

Aclasta Side Effects Report #5595688-6
Physician from FRANCE reported ACLASTA problem on Jan 16, 2008. Male patient, 70 years of age, was diagnosed with osteitis deformans, hypothyroidism and was treated with ACLASTA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood calcium decreased, blood phosphorus decreased, fatigue, osteomalacia, urine calcium decreased, urine phosphate decreased, . ACLASTA dosage: 5 MG, ONCE/SINGLE. During the same period patient was treated with CACIT D, CARVEDILOL, COZAAR, FUROSEMIDE, SPIRONOLACTONE, LEVOTHYROX, DEDROGYL. Patient was hospitalized. Patient recovered.

Trileptal Side Effects Report #5599711-4
TRILEPTAL problem was reported by a Consumer or non-health professional from FRANCE on Jan 17, 2008. Female patient, 44 years of age, weighting 174.2 lb, was diagnosed with neuralgia, rheumatoid arthritis, adrenal insufficiency and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood parathyroid hormone increased, blood phosphorus decreased, hyperparathyroidism secondary, hypocalcaemia, muscle spasms, urine calcium increased, vitamin d decreased, . TRILEPTAL dosage: 120 MG, BID. During the same period patient was treated with PROPOFAN, LAROXYL, LIDOCAINE, METHOTREXATE, LEDERFOLIN, CORTANCYL, HYDROCORTISONE, FLUDROCORTISONE ACETATE. Patient recovered.

Dasatinib Side Effects Report #5506294-3
Consumer or non-health professional from UNITED STATES reported DASATINIB problem on Nov 02, 2007. Male patient, weighting 174.8 lb, was diagnosed with glioblastoma multiforme and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood phosphorus decreased, condition aggravated, lymphopenia, . DASATINIB dosage: 100MG PO BID TOTAL 5600 MG. Patient recovered.

Sprycel Side Effects Report #5523043-3
SPRYCEL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2007. Male patient, weighting 174.8 lb, was diagnosed with glioblastoma multiforme and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood phosphorus decreased, . SPRYCEL dosage: 5600 MG. Patient recovered.

Tenofovir Side Effects Report #5485275-2
Health Professional from UNITED STATES reported TENOFOVIR problem on Oct 10, 2007. Male patient, 60 years of age, weighting 130.5 lb, was diagnosed with hiv infection and was treated with TENOFOVIR. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood alkaline phosphatase increased, blood phosphorus decreased, bone scan abnormal, glucose urine present, osteoporosis, pain in extremity, . TENOFOVIR dosage: 300MG DAILY PO. Patient recovered.